VRPX

Virpax Pharmaceuticals, Inc. Common Stock
VRPX

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

VRPX was delisted on the 3rd of April, 2025.

Back to rankings

8 hedge funds and large institutions have $66.8K invested in Virpax Pharmaceuticals, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

Holders
8
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$21.8K
2
+$19.4K
3
+$13.4K
4
TSS
Two Sigma Securities
New York
+$8.7K
5
TRCT
Tower Research Capital (TRC)
New York
+$470

Top Sellers

1
-$10.3K
2
-$1
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$21.8K
2
$19.4K
3
$14.2K
4
$8.7K
5
$2.66K
6
$35
7
$26
8
$10
9
–
10
–